Healthcare: Never Will I Ever Buy Pre-Clinical Biotech Stocks. No Way!

Industry Focus

The Motley Fool

Interview, Money, Consumergoods, Business, Businessnews, Ceo, Technology, Investing, Stocks, Energy, Fool, Financial, Economy, Healthcare, News, Banking, Motley, Tech, Business News, Investments

4.6 • 854 Ratings

🗓️ 12 July 2017

⏱️ 20 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Only 10% of drugs make it across the FDA finish line from phase 1 clinical trials, making acquiring pre-clinical biotech stocks the riskiest game in town.

Transcript

Click on a timestamp to play from that location

0:00.0	Welcome to Industry Focus, the podcast that dives into a different sector of the stock market every day.
0:07.0	It's July 12th and I'm your health care show host Christine Harjus.
0:11.0	Calling in the rather swampy Alexandria, Virginia is Todd Campbell, a full
0:15.7	dot com health care specialist.
0:17.6	Welcome to the show, Todd.
0:18.8	Anything new and exciting.
0:19.8	Hi, Christine, is it raining there?
0:21.8	Why is it's just just it's really humid.
0:24.0	You know and that they say it's not the heat, it's the humidity, right?
0:28.0	It is, yeah. I have a friend from Georgia who says it's about 10 degrees hotter there
0:32.0	but he can't stand it here just because
0:34.1	of the way the humidity sucks you in.
0:36.5	Oh, and it's so oppressive.
0:38.2	You walk outside and it's just, you start sweating immediately.
0:41.3	It's just no fun. It's a great day to be inside filming a
0:44.4	podcast. It sure is. Yeah, the studio is freezing as usual. Anyway, so this is the Wednesday show and so you guys are listeners hopefully have been
0:54.2	listening for the Monday and Tuesday show but just in case this is the first
0:58.0	industry focus show that you're listening to this week it is never will I ever
1:02.2	week where we're talking about some investing choices that we personally
1:05.8	will never make.
1:07.2	Todd, do you want to do the introduction for our health care, Never Will I Ever?
1:11.6	Never Will I Ever. Never Will I Ever by a preclinical biotech stock solely based on the hyper yes so I'm not
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from The Motley Fool, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Motley Fool and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.